Today: 5. Nov, 2024
Gene-editing company CRISPR Therapeutics (CRSP) saw its stock surge by an impressive 54% in 2023, a remarkable feat in the biotech industry. This remarkable growth can be attributed to a series of key developments and market challenges that the company navigated throughout…
Skylar Olsen, Chief Economist at Zillow, participated in ‘Closing Bell Overtime’ to talk about the current condition of the housing market, potential risks in real estate, and the impact of soaring rent prices on consumers. During the discussion, Olsen offered her expert…
